MALLINCKRODT PLC

History

Year	Detail
1867	The company was founded.
1882	Incorporates in Missouri as Mallinckrodt Chemical Works.
1884	Establishes its first office in New York City.
1924	Introduced iodeikon to the scientific community.
1950	Introduces UROKON SODIUM.
1962	The company acquired Van Pelt & Brown.
1966	Acquires Nuclear Consultants, Inc. of Maryland Heights, Missouri.
1982	Avon acquired Mallinckrodt.
1986	The company was acquired by the International Minerals and Chemical Corporation.
1995	Launched the company's first generic pharmaceutical.
2000	Mallinckrodt was acquired by Tyco International.
2007	Tyco Healthcare got separated from Tyco International and renamed itself as Covidien, an independent company.
2012	The company acquired CNS Therapeutics and its intrathecal therapy products.
2015	The company acquired Ikaria, Inc.
2019	The company completed the sales of wholly owned subsidiary BioVectra Inc.
2021	Received FDA approval of StrataGraft.
2022	Received FDA approval for Terlivaz.
2024	The company got U.S. FDA approval for supplemental new drug application for Acthar Gel.